GlassScriptPhysician profile
Donna Thompson
NPI 1174928980
$1,647.91
in general payments reported to CMS, 2019-2025
20 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $219 · 2023: $292 · 2024: $516 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.04 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $264.31 | 2021-2025 | Winlevi |
| Pfizer INC. | $205.19 | 2022-2025 | |
| Incyte Corporation | $148.55 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $141.37 | 2022-2025 | Nemluvio |
| Amgen INC. | $134.13 | 2023-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $128.42 | 2024 | Tremfya |
| Mayne Pharma Commercial LLC | $62.39 | 2022-2024 | |
| Lilly USA, LLC | $45.95 | 2022-2024 | Olumiant, Taltz |
| Leo Pharma INC. | $39.65 | 2025 | Anzupgo |
| Regeneron Healthcare Solutions, INC. | $35.75 | 2025 | Libtayo |
| Botanix Sb INC | $34.41 | 2025 | Sofdra |
| Convatec INC. | $22.13 | 2025 | |
| Lnhc, INC | $17.68 | 2025 | Zelsuvmi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2023 | Spevigo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $16.84 | 2025 | |
| Almirall LLC | $15.83 | 2025 | Klisyri |
| Viiv Healthcare Company | $14.57 | 2023 | Apretude |
| Arcutis Biotherapeutics, INC. | $13.80 | 2024 | Zoryve |
| Mission Pharmacal Company | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.